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Background
To date, the treatment of adult onset Still’s disease
(AOSD) has been largely empirical; therefore, this study
was conducted to investigate the response to therapy
and prognostic factors of AOSD. We describe the clini-
cal features of 54 Korean patients with AOSD and pro-
vide an analysis of the therapeutic responses and
prognostic factors associated with unfavorable outcomes
and mortality in these cases.
Method
Fifty-four Korean patients with AOSD were enrolled based
on Yamaguchi’s criteria. We retrospectively analyzed the
treatments and prognosis.
Results
Thirty-nine patients (72.2%) were female and the average
age at disease onset was 37.3 years. Twenty-nine patients
had a monocyclic disease (53.7%), five had a polycyclic
(9.3%) and fifteen had a chronic articular disease (27.7%)
and five died (9.3%). The elevated ESR and corticosteroids
refractoriness were associated with poor prognosis
(p=0.023 and p=0.009, respectively). The patients that died
were older than those survived (49.2 ± 11.8 vs 42.2 ± 14
year-old, p=0.024). Forty-two patients were treated with
nonsteroidal anti-inflammatory drugs; however, they also
needed corticosteroids and intravenous immunoglobulin
(IVIG). Among 50 patients treated with high-dose corti-
costeroids, 21 patients (42%) were resistant to corticoster-
oids and treated with IVIG or anti-tumor necrosis factor
(TNF) agents. Of the 23 patients medicated with IVIG, the
prognosis was better in IVIG-responsive patients, indicat-
ing a therapeutic effect. Methotrexate was the most com-
monly used disease modifying antirheumatic drugs
(27 patients, 50%) and the corticosteroid requirements
were lower in the methotrexate-responsive patients.
Conclusion
Approximately a half of Korean AOSD patients had a poor
prognosis including polycyclic or chronic articular disease,
or mortality. In addition, there was no clinical response to
NSAIDs and 42% of patients were corticosteroids resistant
and therefore required IVIG and anti-TNF agents. Metho-
trexate showed a corticosteroid-sparing effect. The ele-
vated serum ESR and non-response to corticosteroids
were significantly associated with poor prognosis. Finally,
patients who died were older than those who survived.
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